Lisa Huynh, MD
Orthopedic Surgery · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Huynh’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A130034 · Current
Licensed to practise in California · since 2014 · expires 2027-07-31 · Albert Einstein College of Medicine of Yeshiva University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$100,534
Medicare paid this office $100,534 for 424 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 264 | $49,667 | $91 |
| New patient visit (45+ min) | 114 | $13,176 | $116 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 97 | $12,943 | $109 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 189 | $4,378 | $15 |
| Long return visit (40+ min) | 28 | $4,302 | $134 |
See all 10 services
| Return visit (30+ min) | 264 | $49,667 | $91 |
| New patient visit (45+ min) | 114 | $13,176 | $116 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 97 | $12,943 | $109 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 189 | $4,378 | $15 |
| Long return visit (40+ min) | 28 | $4,302 | $134 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 28 | $2,783 | $84 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 42 | $2,285 | $51 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 14 | $1,804 | $95 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 24 | $1,408 | $45 |
| Short return visit (20+ min) | 13 | $852 | $66 |
Who their Medicare patients are
424 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 12% · Women 66% · Also on Medicaid 16% · Health risk score 1.06. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 63% · Coronary heart disease 25% · Diabetes 22% · Chronic kidney disease 20% · Cancer 17% · Depression 17% · Atrial fibrillation 14% · Heart failure 10% · COPD 8% · Stroke 6% · Dementia 4%.
The office billed $818,182, Medicare allowed $133,182 and paid $100,534; for 1,331 services of 30 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 424 | 1,331 | 75 | 1.06 | $818,182 | $100,534 |
| 2023 | 338 | 870 | 75 | 1.05 | $677,803 | $74,201 |
| 2022 | 257 | 516 | 75 | 1.05 | $507,286 | $42,051 |
| 2021 | 418 | 978 | 75 | 1.20 | $935,889 | $87,477 |
| 2020 | 307 | 666 | 75 | 1.26 | $600,483 | $52,717 |
| 2019 | 337 | 595 | 75 | 1.22 | $383,444 | $45,451 |
| 2018 | 569 | 1,245 | 74 | 1.26 | $641,849 | $91,509 |
| 2017 | 496 | 930 | 73 | 1.25 | $424,824 | $69,907 |
| 2016 | 357 | 669 | 73 | 1.14 | $409,358 | $52,671 |
| 2015 | 148 | 197 | 72 | 1.32 | $80,403 | $14,367 |
| 2014 | 70 | 82 | 72 | 0.94 | $20,548 | $4,640 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 214 | $34,363 | $79 |
| New patient visit (45+ min) | 124 | $13,490 | $109 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 76 | $9,150 | $108 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 26 | $2,822 | $91 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 18 | $2,335 | $93 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 30 | $1,953 | $54 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 15 | $1,186 | $56 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 14 | $695 | $46 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 15 | $70 | $5 |
2022: 8 services
| Return visit (30+ min) | 148 | $18,388 | $77 |
| New patient visit (45+ min) | 91 | $8,827 | $97 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 57 | $5,789 | $100 |
| Long return visit (40+ min) | 17 | $2,159 | $120 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 22 | $2,056 | $86 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 16 | $830 | $52 |
| Aspiration and/or injection of fluid from large joint | 11 | $397 | $31 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 11 | $52 | $4 |
2021: 10 services
| Return visit (30+ min) | 225 | $34,958 | $85 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 108 | $14,611 | $112 |
| New patient visit (45+ min) | 122 | $14,273 | $117 |
| Long return visit (40+ min) | 44 | $5,813 | $126 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 31 | $3,246 | $88 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 34 | $1,989 | $54 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 16 | $1,530 | $81 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 24 | $1,280 | $46 |
| Short return visit (20+ min) | 20 | $1,081 | $51 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 19 | $236 | $11 |
2020: 13 services
| Return visit (30+ min) | 141 | $15,621 | $68 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 73 | $10,059 | $118 |
| New patient visit (45+ min) | 74 | $7,289 | $98 |
| Long return visit (40+ min) | 73 | $6,969 | $94 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 16 | $2,398 | $114 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 19 | $1,760 | $88 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 21 | $1,162 | $46 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,091 | $73 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 13 | $939 | $52 |
| New patient visit (30+ min) | 15 | $888 | $59 |
| Short return visit (20+ min) | 11 | $543 | $49 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 11 | $533 | $48 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 18 | $201 | $11 |
2019: 10 services
| Return visit (30+ min) | 153 | $13,063 | $61 |
| New patient visit (45+ min) | 82 | $8,413 | $103 |
| Long return visit (40+ min) | 82 | $7,940 | $96 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 52 | $6,063 | $106 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 17 | $2,185 | $91 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 15 | $1,419 | $79 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 21 | $1,176 | $53 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 11 | $878 | $52 |
| Short return visit (20+ min) | 13 | $597 | $46 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | $165 | $11 |
2018: 13 services
| Return visit (30+ min) | 234 | $26,413 | $67 |
| New patient visit (45+ min) | 145 | $15,595 | $108 |
| Long return visit (40+ min) | 146 | $14,627 | $99 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 110 | $13,949 | $112 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 52 | $3,166 | $58 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 20 | $2,953 | $102 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 20 | $2,135 | $85 |
| Aspiration and/or injection of fluid from large joint | 37 | $1,566 | $40 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 14 | $1,345 | $58 |
| Short return visit (20+ min) | 24 | $1,094 | $44 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 18 | $863 | $48 |
| Fluoroscopic guidance for needle placement | 26 | $652 | $24 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 40 | $524 | $11 |
2017: 10 services
| Return visit (30+ min) | 192 | $19,315 | $67 |
| New patient visit (45+ min) | 141 | $14,444 | $102 |
| Long return visit (40+ min) | 106 | $10,492 | $96 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 77 | $10,080 | $112 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 82 | $5,128 | $56 |
| Short return visit (20+ min) | 69 | $3,269 | $42 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 13 | $1,506 | $94 |
| New patient visit (30+ min) | 22 | $1,444 | $66 |
| Aspiration and/or injection of fluid from large joint | 19 | $742 | $39 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 17 | $239 | $11 |
2016: 10 services
| Return visit (30+ min) | 147 | $13,705 | $70 |
| New patient visit (45+ min) | 117 | $12,862 | $110 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 39 | $5,251 | $114 |
| Long return visit (40+ min) | 48 | $4,661 | $97 |
| Short return visit (20+ min) | 77 | $4,282 | $47 |
| New patient visit (30+ min) | 42 | $2,817 | $67 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 14 | $1,786 | $105 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 25 | $1,771 | $63 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 11 | $801 | $57 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 13 | $620 | $39 |
2015: 6 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,556 | $122 |
| Short return visit (20+ min) | 46 | $2,182 | $45 |
| New patient visit (45+ min) | 16 | $1,808 | $113 |
| Return visit (30+ min) | 14 | $1,266 | $70 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,253 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,140 | $63 |
2014: 1 service
| Short return visit (20+ min) | 40 | $1,913 | $46 |
Medicaid work
$8,873 in 2024
Medicaid paid $8,873 for 148 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 136 | $8,837 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 12 | $36 |
| 2024 | 148 | 2 | 18 | $8,873 |
| 2023 | 142 | 1 | 21 | $4,569 |
| 2022 | 48 | 1 | 18 | $1,353 |
| 2021 | 87 | 1 | 20 | $3,104 |
| 2020 | 62 | 1 | 17 | $2,851 |
| 2019 | 34 | 1 | 18 | $1,181 |
| 2018 | 62 | 1 | 18 | $2,479 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 142 | $4,569 |
2022
| Return visit (30+ min) | 48 | $1,353 |
2021
| Return visit (30+ min) | 87 | $3,104 |
2020
| Return visit (30+ min) | 62 | $2,851 |
2019
| Return visit (30+ min) | 34 | $1,181 |
2018
| Return visit (30+ min) | 62 | $2,479 |
Drugs they prescribed that Part D paid
$1,376
Pharmacies billed $1,376 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 11% of their Part D prescriptions (12 of 111) in 2024. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 31%.
111 generic and 0 brand-name prescriptions · $1,376 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gabapentin | 27 | $451 | $12 |
| Methocarbamol | 11 | $147 | $12 |
| Naproxen | 13 | $66 | $5 |
Year by year
| 2024 | 111 | 66 | 11% (12) | 0% | $1,376 |
| 2023 | 101 | 54 | None | None | $1,813 |
| 2022 | 87 | 48 | None | None | $1,372 |
| 2021 | 110 | 63 | None | 0% | $1,231 |
| 2020 | 104 | 60 | None | 0% | $1,641 |
| 2019 | 111 | 62 | None | None | $1,802 |
| 2018 | 198 | 92 | None | None | $2,751 |
| 2017 | 165 | 79 | 7% (12) | 16% | $2,172 |
| 2016 | 128 | 74 | 14% (18) | 13% | $2,948 |
| 2015 | 34 | 25 | None | None | $946 |
| 2014 | 32 | 13 | None | None | $1,980 |
| 2013 | 131 | 28 | None | None | $7,319 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Gabapentin | 46 | $767 | $17 |
| Methocarbamol | 12 | $248 | $21 |
| Meloxicam | 12 | $64 | $5 |
2022: 1 drug
| Gabapentin | 50 | $810 | $16 |
2021: 4 drugs
| Gabapentin | 49 | $437 | $9 |
| Methocarbamol | 11 | $260 | $24 |
| Diclofenac | 13 | $259 | $20 |
| Meloxicam | 13 | $114 | $9 |
2020: 2 drugs
| Gabapentin | 59 | $786 | $13 |
| Diclofenac | 14 | $403 | $29 |
2019: 1 drug
| Gabapentin | 75 | $1,115 | $15 |
2018: 2 drugs
| Gabapentin | 111 | $1,420 | $13 |
| Naproxen | 24 | $306 | $13 |
2017: 2 drugs
| Gabapentin | 94 | $872 | $9 |
| Diclofenac | 22 | $656 | $30 |
2016: 4 drugs
| Gabapentin | 46 | $634 | $14 |
| Voltaren | 11 | $539 | $49 |
| Tramadol | 17 | $84 | $5 |
| Meloxicam | 19 | $70 | $4 |
2015: 1 drug
| Meloxicam | 16 | $61 | $4 |
Money from drug and device companies
$39 in 2025
| 2025 | 1 | 1 | None | $39 |
| 2021 | 1 | 2 | None | $44 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Intracept | $39 | 1 payment
|
See the published payment
| Boston Scientific | Meals · 2025-09-17 | Intracept | $39 |
See earlier years (2021)
2021: $44
| Relievant Medsystems | Intracept | $44 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1245529775
- Licence
- CA A130034California A130034: Current · expires 2027-07-31
- Trained
- University of Pittsburgh School of Medicine, 2014
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 208100000X (208100000X); Orthopedic surgery (207X00000X)
- Mailing address
- 450 Broadway St # Mc6342, Redwood City, CA, 94063
- NPI first listed
- 2011-04-05
- NPI last updated
- 2024-04-28
- NPI record certified
- 2024-04-28
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 450 Broadway St # Mc6342, Redwood City, CA, 94063